Man Group’s Transmedics TMDX Stock Holding History

Man Group’s Portfolio TMDX Stock Details TMDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$15.7M	Buy	158,409 +62,745	+66%	+$8.18M	0.03%	612
2025 Q4	$11.6M	Sell	95,664 -17,892	-16%	-$2.25M	0.02%	726
2025 Q3	$12.7M	Buy	113,556 +88,914	+361%	+$10.4M	0.02%	686
2025 Q2	$3.3M	Buy	+24,642	New	+$2.71M	0.01%	1238
2025 Q1	–	Sell	-395,447	Closed	-$24.7M	–	2368
2024 Q4	$24.7M	Buy	395,447 +50,127	+15%	+$4.67M	0.06%	355
2024 Q3	$54.2M	Buy	+345,320	New	+$53.2M	0.14%	170
2023 Q3	–	Hold	0	–	–	–	1448
2022 Q2	–	Hold	0	–	–	–	1610
2021 Q4	–	Sell	-26,199	Closed	-$867K	–	2108
2021 Q3	$867K	Buy	26,199 +7,600	+41%	+$232K	﹤0.01%	1374
2021 Q2	$617K	Buy	+18,599	New	+$515K	﹤0.01%	1504
2020 Q4	–	Sell	-15,400	Closed	-$212K	–	1935
2020 Q3	$212K	Buy	+15,400	New	+$264K	﹤0.01%	1696

Other funds holding TMDX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Man Group's TMDX Position: Q1 2026 in Review

Man Group increased its Transmedics (TMDX) stake by 66% in Q1 2026, buying an estimated $8.18M and bringing the position to 158,409 shares worth $15.7M. The position accounts for 0.03% of the portfolio, ranked #612.

Man Group first reported a position in TMDX in Q3 2020 and has held it in 9 quarters since. The position peaked at $54.2M in Q3 2024. 414 funds tracked by Wall St. Rank hold TMDX as of Q1 2026.

Man Group held 158,409 shares of Transmedics worth $15.7M as of Q1 2026.
Man Group bought 62,745 Transmedics shares in Q1 2026, an estimated $8.18M.
Transmedics made up 0.03% of Man Group's portfolio in Q1 2026, its #612 holding.
Man Group first reported a position in Transmedics in Q3 2020 and has held it in 9 quarters since.
Man Group's Transmedics position peaked at $54.2M in Q3 2024.
414 funds tracked by Wall St. Rank held Transmedics as of Q1 2026.

Based on Man Group's 13F filing for Q1 2026, filed 15 May 2026.